Sildenafil(SDN) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-Sildenafil (SDN) antibodies (anti-Sildenafil, anti-SDN) and diagnostic hapten-carrier conjugates BSA-Sildenafil (SDN), OVA-Sildenafil (SDN), KLH-Sildenafil (SDN) antigens for Cardiovascular disease SDN detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Cardiovascular disease diagnostics products collection>>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Sildenafil(SDN)

OVA-Sildenafil(SDN)

Anti-human Sildenafil(SDN) mouse monoclonal antibody (mAb)

Anti-human Sildenafil(SDN) human monoclonal antibody (mAb)

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Sildenafil: A Comprehensive Exploration in In Vitro Diagnosis (IVD)

Sildenafil, a prominent pharmaceutical compound, has garnered widespread recognition for its therapeutic applications, particularly in addressing conditions such as erectile dysfunction and pulmonary arterial hypertension. Its pharmacological prowess lies in its potent inhibition of phosphodiesterase type 5 (PDE5), resulting in the relaxation of blood vessels and the subsequent improvement of blood circulation. This mechanism underpins its efficacy in facilitating erections and alleviating pulmonary hypertension.

In the realm of in vitro diagnosis (IVD), Sildenafil plays a pivotal role as a target molecule for diagnostic assays. Our esteemed biopharmaceutical enterprise specializes in the provision of anti-Sildenafil antibodies and an extensive range of small molecule competitive antigens. This diverse portfolio encompasses an array of variants, including Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated forms. Each component within this meticulously engineered collection is designed with precision to facilitate the development of advanced diagnostic assays, enabling the accurate, sensitive, and reliable quantification of Sildenafil levels within diverse biological samples.

2. The Multifaceted Significance of Sildenafil Measurement

The measurement of Sildenafil holds profound importance across various domains, spanning clinical therapeutics, patient care, research, and drug development:

a. Optimizing Therapeutic Efficacy: Sildenafil is prescribed to individuals grappling with conditions like erectile dysfunction and pulmonary arterial hypertension. Accurate measurement of Sildenafil levels is instrumental in ensuring that patients receive the appropriate dosage, thereby optimizing therapeutic response and enhancing patient well-being.

b. Facilitating Treatment Monitoring: Continuous monitoring of Sildenafil levels empowers healthcare practitioners to assess treatment progress and make requisite adjustments. This approach strives for optimal therapeutic outcomes while mitigating potential side effects, ultimately enhancing patient care.

c. Enhancing Safety and Compliance: Precise measurement of Sildenafil attests to patient adherence to prescribed medication regimens. It enhances treatment compliance and minimizes the likelihood of adverse events, ensuring patient safety remains paramount.

d. Enabling Scientific Exploration: Beyond its clinical utility, Sildenafil measurement significantly contributes to the realm of scientific research and drug development. It serves as a linchpin in elucidating the pharmacokinetics, metabolic pathways, and prospective applications of Sildenafil beyond its established therapeutic indications. This knowledge fuels innovation and drives the development of new therapeutic interventions.

e. Point-of-Care Diagnostics: In the context of point-of-care testing (POCT), accurate Sildenafil measurement can be pivotal. It empowers healthcare professionals to make real-time clinical decisions, especially in situations where immediate assessment is critical.

In conclusion, the precision in measuring Sildenafil levels within the context of in vitro diagnosis (IVD) emerges as an indispensable and multifaceted facet of healthcare and scientific exploration. This precision profoundly impacts therapeutic efficacy, facilitates treatment monitoring, bolsters patient safety, and fuels scientific innovation. Our specialized product portfolio, meticulously tailored for Sildenafil assessment, stands as a cornerstone in enabling accurate and sensitive quantification of this pharmaceutical compound. By doing so, it not only advances patient care and elevates safety standards but also contributes to the ongoing progress in pharmacology and therapeutic development, ushering in new horizons for healthcare and medical research.

About GDU